Consensus Sinopharm Group Co. Ltd.

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-05-10 am EDT			5-day change	1st Jan Change
21.5 ^HKD	+3.61%		+10.71%	+5.13%

Apr. 29	Wall Street Cues, Property Outlooks Lift Asian Stock Markets	MT
Apr. 29	China, Hong Kong stocks rise, led by property shares	RE

267cdcd3.x24K4yPTkuFh75ZJjvIcMLjuDC_3z86Uh8_juBuRfuA.8VpkvGyk5JQSueAg5N9oSo-sOGOF_pzssqaa7lrCP5i_N1KZdOaqhSi-3w~46dfa950b98eb0d5e9aab4c3cc1e2cfb

Nomura Adjusts Sinopharm Group’s Price Target to HK$32.39 Form HK$33.31, Keeps at Buy	Mar. 11	MT
Interest Rates, Earnings, FX Roil Asian Stock Markets	Nov. 24	MT
Nomura Adjusts Sinopharm Group's Price Target to HK$33.31 From HK$36.28, Keeps at Buy	23-10-19	MT
Nomura Adjusts Sinopharm's Price Target to HK$36.28 From HK$36.88, Keeps at Buy	23-07-27	MT
UBS Adjusts Sinopharm Group's Price Target to HK$26 From HK$28, Keeps at Buy	22-08-31	MT
UBS Adjusts Sinopharm's Price Target to HK$28 From HK$30, Keeps at Buy	22-03-25	MT
WHO sees more evidence that Omicron causes milder symptoms	22-01-04	RE
WHO sees more evidence that Omicron causes milder symptoms	22-01-04	RE
Kenya to start giving COVID-19 booster shots	21-12-25	RE
Sinovac Biotech : China considers mixing COVID-19 vaccines to boost protection rate	21-04-11	RE
Sinovac Biotech : China considering mixing COVID-19 vaccines due to low efficacy rates	21-04-11	RE

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

19.88 CNY

Average target price

24.61 CNY

Spread / Average Target

+23.79%

High Price Target

29.96 CNY

Spread / Highest target

+50.70%

Low Price Target

19.58 CNY

Spread / Lowest Target

-1.50%

Nomura
UBS

Trading Rating

Investor Rating

ESG Refinitiv